ATE186732T1 - (e)-2'-deoxy-2'-(fluormethylen)cytidin-monohydr t - Google Patents
(e)-2'-deoxy-2'-(fluormethylen)cytidin-monohydr tInfo
- Publication number
- ATE186732T1 ATE186732T1 AT95907232T AT95907232T ATE186732T1 AT E186732 T1 ATE186732 T1 AT E186732T1 AT 95907232 T AT95907232 T AT 95907232T AT 95907232 T AT95907232 T AT 95907232T AT E186732 T1 ATE186732 T1 AT E186732T1
- Authority
- AT
- Austria
- Prior art keywords
- fluoromethylene
- cytidine
- deoxy
- monohydr
- neoplastic
- Prior art date
Links
- GFFXZLZWLOBBLO-ASKVSEFXSA-N tezacitabine Chemical compound O=C1N=C(N)C=CN1[C@H]1C(=C/F)/[C@H](O)[C@@H](CO)O1 GFFXZLZWLOBBLO-ASKVSEFXSA-N 0.000 title abstract 2
- 229940123934 Reductase inhibitor Drugs 0.000 abstract 1
- 102000000505 Ribonucleotide Reductases Human genes 0.000 abstract 1
- 108010041388 Ribonucleotide Reductases Proteins 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 150000004682 monohydrates Chemical class 0.000 abstract 1
- 230000001613 neoplastic effect Effects 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17895294A | 1994-01-07 | 1994-01-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE186732T1 true ATE186732T1 (de) | 1999-12-15 |
Family
ID=22654587
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT95907232T ATE186732T1 (de) | 1994-01-07 | 1994-12-13 | (e)-2'-deoxy-2'-(fluormethylen)cytidin-monohydr t |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP0738273B1 (de) |
| JP (1) | JPH09511227A (de) |
| KR (1) | KR100330328B1 (de) |
| CN (1) | CN1043231C (de) |
| AT (1) | ATE186732T1 (de) |
| AU (1) | AU684604B2 (de) |
| CA (1) | CA2179987C (de) |
| DE (1) | DE69421721T2 (de) |
| DK (1) | DK0738273T3 (de) |
| ES (1) | ES2141330T3 (de) |
| FI (1) | FI114396B (de) |
| GR (1) | GR3032614T3 (de) |
| HU (1) | HU217849B (de) |
| IL (1) | IL112242A (de) |
| MX (1) | MX9500363A (de) |
| NO (1) | NO306409B1 (de) |
| NZ (1) | NZ279030A (de) |
| TW (1) | TW397838B (de) |
| WO (1) | WO1995018815A1 (de) |
| ZA (1) | ZA9512B (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1130363C (zh) | 1997-11-12 | 2003-12-10 | 三菱化学株式会社 | 嘌呤衍生物以及含有其作为有效成分的药物 |
| WO2000068231A1 (en) | 1999-05-11 | 2000-11-16 | Mitsubishi Chemical Corporation | Purine derivative dihydrate, drugs containing the same as the active ingredient and intermediate in the production thereof |
| TW202547461A (zh) | 2024-05-17 | 2025-12-16 | 美商銳新醫藥公司 | Ｒａｓ抑制劑 |
| WO2025255438A1 (en) | 2024-06-07 | 2025-12-11 | Revolution Medicines, Inc. | Methods of treating a ras protein-related disease or disorder |
| WO2025265060A1 (en) | 2024-06-21 | 2025-12-26 | Revolution Medicines, Inc. | Therapeutic compositions and methods for managing treatment-related effects |
| WO2026006747A1 (en) | 2024-06-28 | 2026-01-02 | Revolution Medicines, Inc. | Ras inhibitors |
| WO2026015790A1 (en) | 2024-07-12 | 2026-01-15 | Revolution Medicines, Inc. | Methods of treating a ras related disease or disorder |
| WO2026015801A1 (en) | 2024-07-12 | 2026-01-15 | Revolution Medicines, Inc. | Methods of treating a ras related disease or disorder |
| WO2026015796A1 (en) | 2024-07-12 | 2026-01-15 | Revolution Medicines, Inc. | Methods of treating a ras related disease or disorder |
| WO2026015825A1 (en) | 2024-07-12 | 2026-01-15 | Revolution Medicines, Inc. | Use of ras inhibitor for treating pancreatic cancer |
| WO2026050446A1 (en) | 2024-08-29 | 2026-03-05 | Revolution Medicines, Inc. | Ras inhibitors |
| WO2026072904A2 (en) | 2024-09-26 | 2026-04-02 | Revolution Medicines, Inc. | Compositions and methods for treating lung cancer |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA898567B (en) * | 1988-11-15 | 1990-08-29 | Merrell Dow Pharma | Novel 2'-halomethylidene,2'-ethenylidene and 2'-ethynyl cytidine,uridine and guanosine derivatives |
| FI95269C (fi) * | 1989-05-15 | 1996-01-10 | Squibb Bristol Myers Co | 2',3'-dideoksi-inosiinimonohydraatin, 2',3'-dideoksi-2',3'-didehydrot ymidiinimonohydraatin ja 2',3'-dideoksi-2'-fluori-inosiinihemihydraatin antiviraalisia, hyvin vesiliukoisia, stabiileja, kiteisiä suoloja |
| JPH0615557B2 (ja) * | 1990-02-19 | 1994-03-02 | ヤマサ醤油株式会社 | ２’―デオキシ―２’―メチリデンシチジンの２水和物結晶 |
| JP3265548B2 (ja) * | 1992-05-12 | 2002-03-11 | メレルファーマス−ティカルズ インコーポレイテッド | リボヌクレオチド還元酵素阻害剤の製法 |
-
1994
- 1994-12-13 AT AT95907232T patent/ATE186732T1/de not_active IP Right Cessation
- 1994-12-13 CN CN94194779A patent/CN1043231C/zh not_active Expired - Fee Related
- 1994-12-13 EP EP95907232A patent/EP0738273B1/de not_active Expired - Lifetime
- 1994-12-13 WO PCT/US1994/014648 patent/WO1995018815A1/en not_active Ceased
- 1994-12-13 DE DE69421721T patent/DE69421721T2/de not_active Expired - Fee Related
- 1994-12-13 HU HU9601848A patent/HU217849B/hu not_active IP Right Cessation
- 1994-12-13 NZ NZ279030A patent/NZ279030A/en unknown
- 1994-12-13 ES ES95907232T patent/ES2141330T3/es not_active Expired - Lifetime
- 1994-12-13 AU AU15532/95A patent/AU684604B2/en not_active Ceased
- 1994-12-13 JP JP7518503A patent/JPH09511227A/ja active Pending
- 1994-12-13 CA CA002179987A patent/CA2179987C/en not_active Expired - Fee Related
- 1994-12-13 KR KR1019960703658A patent/KR100330328B1/ko not_active Expired - Fee Related
- 1994-12-13 DK DK95907232T patent/DK0738273T3/da active
-
1995
- 1995-01-03 ZA ZA9512A patent/ZA9512B/xx unknown
- 1995-01-04 IL IL11224295A patent/IL112242A/xx not_active IP Right Cessation
- 1995-01-04 TW TW084100012A patent/TW397838B/zh not_active IP Right Cessation
- 1995-01-06 MX MX9500363A patent/MX9500363A/es unknown
-
1996
- 1996-07-05 FI FI962769A patent/FI114396B/fi active IP Right Grant
- 1996-07-05 NO NO962848A patent/NO306409B1/no unknown
-
2000
- 2000-02-09 GR GR20000400313T patent/GR3032614T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| FI962769L (fi) | 1996-07-05 |
| NO962848L (no) | 1996-09-06 |
| HU217849B (hu) | 2000-04-28 |
| CN1141045A (zh) | 1997-01-22 |
| DE69421721T2 (de) | 2000-04-27 |
| AU684604B2 (en) | 1997-12-18 |
| WO1995018815A1 (en) | 1995-07-13 |
| TW397838B (en) | 2000-07-11 |
| DK0738273T3 (da) | 2000-04-17 |
| IL112242A0 (en) | 1995-03-30 |
| FI962769A0 (fi) | 1996-07-05 |
| GR3032614T3 (en) | 2000-05-31 |
| AU1553295A (en) | 1995-08-01 |
| HU9601848D0 (en) | 1996-09-30 |
| CA2179987C (en) | 1999-01-19 |
| NZ279030A (en) | 1997-05-26 |
| ES2141330T3 (es) | 2000-03-16 |
| NO306409B1 (no) | 1999-11-01 |
| EP0738273B1 (de) | 1999-11-17 |
| DE69421721D1 (de) | 1999-12-23 |
| IL112242A (en) | 2000-08-31 |
| CA2179987A1 (en) | 1995-07-13 |
| JPH09511227A (ja) | 1997-11-11 |
| EP0738273A1 (de) | 1996-10-23 |
| HUT75055A (en) | 1997-03-28 |
| NO962848D0 (no) | 1996-07-05 |
| KR100330328B1 (ko) | 2002-12-05 |
| MX9500363A (es) | 1998-04-30 |
| CN1043231C (zh) | 1999-05-05 |
| ZA9512B (en) | 1995-09-11 |
| FI114396B (fi) | 2004-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR199701212T1 (xx) | �drar� tutamama halinin tedavisi i�in alfa IL- agonistlerinin kullan�lmas�. | |
| ATE186732T1 (de) | (e)-2'-deoxy-2'-(fluormethylen)cytidin-monohydr t | |
| BRPI9506596B8 (pt) | composto l-nucleosídeo. | |
| PT755249E (pt) | Utilizacao de inibidores da reaccao de maillard para o tratamento de doenca com base em amiloidose | |
| ES2191292T3 (es) | Compuestos antivirales poliaromaticos. | |
| CA2002648A1 (en) | 2'-halomethylidene, 2'-ethenylidene and 2'-ethynyl cytidine, uridine and guanosine derivatives | |
| DE69521122D1 (de) | 2,3,4,5-tetrahydro-1h-3-benzazepin säure-additions-salze | |
| DK630589D0 (da) | 2',3'-dideoxypurinnucleosid/purinnucleosid-phosphorylase-inhibitor-sammensaetning | |
| BR9811643A (pt) | Suplementação quìmica de osso | |
| BR9810616A (pt) | Inibidores de farnesil transferase em combinação com inibidores de hmg coa redutase para o tratamento do cancer | |
| DK0625158T3 (da) | Terapeutiske nucleosider af 2',3'-dideoxy-3'-fluorpurinrækken | |
| MY124071A (en) | Treatment of viral disease in swine | |
| MC1930A1 (fr) | Produit antiviral | |
| BR9916043A (pt) | Composto, uso do mesmo e de seus saisfarmaceuticamente aceitáveis, e, composiçãofarmacêutica para tratamento de infecções deherpes viral em pacientes | |
| BR9808564A (pt) | Método de tratar um paciente tendo infecções por hiv | |
| ES2053686T3 (es) | Nuevos di(met)acrilatos, procedimiento para su fabricacion y su empleo. | |
| DK0459176T3 (da) | Oligophosphater med antiviral virkning | |
| ES2085023T3 (es) | Procedimientos para la produccion de zidovudina. | |
| BR0012380A (pt) | 2-amino-benzoxazinonas para o tratamento de vìrus do herpes simples | |
| AR015724A1 (es) | La utilizacion de un inhibidor del intercambiador entre na+ y h+ para la preparacion de un medicamento destinado al tratamiento o a la profilaxia deenfermedades del sistema nervioso central. | |
| BR9906931A (pt) | Triazepinonas, processo para sua preparação e sua aplicação terapêutica | |
| LTIP1943A (en) | Arylating agents, used in the treatment of cancerand disease caused by viral infection | |
| ES2181160T3 (es) | Derivados de 1,4-dihidropiridina y su utilizacion en terapia. | |
| IT1263041B (it) | Derivati di s,s'-bis(carbossammidofenil)-disolfuro ad attivita' cardiovascolare | |
| ES2116574T3 (es) | 4-guanidinobutiramida para mejorar la circulacion de la sangre. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |